{"id":330133,"date":"2026-10-28T11:49:41","date_gmt":"2026-10-28T06:19:41","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=330133"},"modified":"2026-10-28T11:49:41","modified_gmt":"2026-10-28T06:19:41","slug":"fo-stocks-to-buy-cdsl-zydus-lifesciences-and-sun-pharma-on-jay-thakkars-near-term-list-price-levels-technicals-and-risks","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/fo-stocks-to-buy-cdsl-zydus-lifesciences-and-sun-pharma-on-jay-thakkars-near-term-list-price-levels-technicals-and-risks\/","title":{"rendered":"F&amp;O Stocks to Buy: CDSL, Zydus Lifesciences and Sun Pharma on Jay Thakkar&#8217;s Near-Term List, With Price Levels, Technicals and Risks"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>The F&amp;O stocks to buy named by ICICI Securities analyst Jay Thakkar for the near term are CDSL at Rs 1,223.60, Zydus Lifesciences at Rs 1,177.60 and Sun Pharma at Rs 1,746.90 on the NSE at 11:26 AM on Wednesday, 28 Oct 2026. Thakkar said markets may stay range-bound ahead of key events after the Sensex and Nifty ended Tuesday slightly lower amid elevated oil prices and geopolitical uncertainty.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The F&amp;O stocks to buy on Jay Thakkar&#8217;s near-term list are CDSL, Zydus Lifesciences and Sun Pharma, chosen while he expects the Nifty 50 and Bank Nifty to stay range-bound ahead of key events. I could not retrieve his buy ranges, targets or stop losses, so this article shows the data instead: Zydus and Sun Pharma have a rising Supertrend, while CDSL is in a downtrend with an RSI of 37.7. Their trailing price to earnings multiples are about 54 for CDSL, 25 for Zydus and 35 for Sun Pharma, and trades in F&amp;O stocks need a stop loss and a margin buffer. This is educational and not a recommendation.<\/p>\n<\/p><\/div>\n<p>F&amp;O stocks to buy are stocks that trade in the futures and options segment and are picked for a near-term move, so the price levels and risk matter more than the story. This article shows the F&amp;O stocks to buy named by Jay Thakkar, the price and technical data for each, the fundamentals and the risks of trading them in a market that fell as much as 1.1% this morning.<\/p>\n<p>I could not find the full report, so I do not have his entry zones, targets or stop losses, and I have not made any up. The levels below come from the data provider&#8217;s indicators and are not his levels. Lot sizes and expiry details are also not covered. It is educational and not advice.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=fo-stocks-to-buy-cdsl-zydus-lifesciences-and-sun-pharma-on-jay-thakkars-near-term-list-price-levels-technicals-and-risks\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/fo-stocks-to-buy-cdsl-zydus-lifesciences-and-sun-pharma-on-jay-thakkars-near-term-list-price-levels-technicals-and-risks\/#F_O_Stocks_to_Buy_Price_and_Technical_Snapshot\" title=\"F&amp;O Stocks to Buy: Price and Technical Snapshot\">F&amp;O Stocks to Buy: Price and Technical Snapshot<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/fo-stocks-to-buy-cdsl-zydus-lifesciences-and-sun-pharma-on-jay-thakkars-near-term-list-price-levels-technicals-and-risks\/#Why_Range-Bound_Markets_Matter_for_F_O_Stocks_to_Buy\" title=\"Why Range-Bound Markets Matter for F&amp;O Stocks to Buy\">Why Range-Bound Markets Matter for F&amp;O Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/fo-stocks-to-buy-cdsl-zydus-lifesciences-and-sun-pharma-on-jay-thakkars-near-term-list-price-levels-technicals-and-risks\/#CDSL_Share_Price_and_Fundamentals\" title=\"CDSL Share Price and Fundamentals\">CDSL Share Price and Fundamentals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/fo-stocks-to-buy-cdsl-zydus-lifesciences-and-sun-pharma-on-jay-thakkars-near-term-list-price-levels-technicals-and-risks\/#Zydus_Lifesciences_Share_Price_and_Fundamentals\" title=\"Zydus Lifesciences Share Price and Fundamentals\">Zydus Lifesciences Share Price and Fundamentals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/fo-stocks-to-buy-cdsl-zydus-lifesciences-and-sun-pharma-on-jay-thakkars-near-term-list-price-levels-technicals-and-risks\/#Sun_Pharma_Share_Price_and_Fundamentals\" title=\"Sun Pharma Share Price and Fundamentals\">Sun Pharma Share Price and Fundamentals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/fo-stocks-to-buy-cdsl-zydus-lifesciences-and-sun-pharma-on-jay-thakkars-near-term-list-price-levels-technicals-and-risks\/#Risks_When_Trading_F_O_Stocks_to_Buy\" title=\"Risks When Trading F&amp;O Stocks to Buy\">Risks When Trading F&amp;O Stocks to Buy<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/fo-stocks-to-buy-cdsl-zydus-lifesciences-and-sun-pharma-on-jay-thakkars-near-term-list-price-levels-technicals-and-risks\/#Conclusion_F_O_Stocks_to_Buy_Need_Defined_Risk\" title=\"Conclusion: F&amp;O Stocks to Buy Need Defined Risk\">Conclusion: F&amp;O Stocks to Buy Need Defined Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/fo-stocks-to-buy-cdsl-zydus-lifesciences-and-sun-pharma-on-jay-thakkars-near-term-list-price-levels-technicals-and-risks\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/fo-stocks-to-buy-cdsl-zydus-lifesciences-and-sun-pharma-on-jay-thakkars-near-term-list-price-levels-technicals-and-risks\/#Which_F_O_stocks_to_buy_did_Jay_Thakkar_name\" title=\"Which F&amp;O stocks to buy did Jay Thakkar name?\">Which F&amp;O stocks to buy did Jay Thakkar name?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/fo-stocks-to-buy-cdsl-zydus-lifesciences-and-sun-pharma-on-jay-thakkars-near-term-list-price-levels-technicals-and-risks\/#What_is_Jay_Thakkars_view_on_the_market\" title=\"What is Jay Thakkar&#8217;s view on the market?\">What is Jay Thakkar&#8217;s view on the market?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/fo-stocks-to-buy-cdsl-zydus-lifesciences-and-sun-pharma-on-jay-thakkars-near-term-list-price-levels-technicals-and-risks\/#What_are_the_CDSL_share_price_and_technicals\" title=\"What are the CDSL share price and technicals?\">What are the CDSL share price and technicals?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/fo-stocks-to-buy-cdsl-zydus-lifesciences-and-sun-pharma-on-jay-thakkars-near-term-list-price-levels-technicals-and-risks\/#What_are_the_Zydus_Lifesciences_share_price_and_technicals\" title=\"What are the Zydus Lifesciences share price and technicals?\">What are the Zydus Lifesciences share price and technicals?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/fo-stocks-to-buy-cdsl-zydus-lifesciences-and-sun-pharma-on-jay-thakkars-near-term-list-price-levels-technicals-and-risks\/#What_are_the_Sun_Pharma_share_price_and_technicals\" title=\"What are the Sun Pharma share price and technicals?\">What are the Sun Pharma share price and technicals?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/fo-stocks-to-buy-cdsl-zydus-lifesciences-and-sun-pharma-on-jay-thakkars-near-term-list-price-levels-technicals-and-risks\/#Where_can_I_find_the_original_report_with_the_levels\" title=\"Where can I find the original report with the levels?\">Where can I find the original report with the levels?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/fo-stocks-to-buy-cdsl-zydus-lifesciences-and-sun-pharma-on-jay-thakkars-near-term-list-price-levels-technicals-and-risks\/#Are_F_O_stocks_to_buy_safe_for_beginners\" title=\"Are F&amp;O stocks to buy safe for beginners?\">Are F&amp;O stocks to buy safe for beginners?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/fo-stocks-to-buy-cdsl-zydus-lifesciences-and-sun-pharma-on-jay-thakkars-near-term-list-price-levels-technicals-and-risks\/#Is_this_article_investment_advice\" title=\"Is this article investment advice?\">Is this article investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"F_O_Stocks_to_Buy_Price_and_Technical_Snapshot\"><\/span><strong>F&amp;O Stocks to Buy: Price and Technical Snapshot<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"text-align:left;padding:8px;border:1px solid #DDDDDD;background:#0A0E1A;color:#FFFFFF;\">F&amp;O stocks to buy: stock<\/th>\n<th style=\"text-align:left;padding:8px;border:1px solid #DDDDDD;background:#0A0E1A;color:#FFFFFF;\">NSE price (11:26 AM)<\/th>\n<th style=\"text-align:left;padding:8px;border:1px solid #DDDDDD;background:#0A0E1A;color:#FFFFFF;\">RSI (14)<\/th>\n<th style=\"text-align:left;padding:8px;border:1px solid #DDDDDD;background:#0A0E1A;color:#FFFFFF;\">20-day EMA<\/th>\n<th style=\"text-align:left;padding:8px;border:1px solid #DDDDDD;background:#0A0E1A;color:#FFFFFF;\">Supertrend (10, 3)<\/th>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">CDSL<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Rs 1,223.60, up 0.13%<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">37.7<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Rs 1,249.03<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Down; resistance Rs 1,280.73; lower band Rs 1,124.14<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Zydus Lifesciences<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Rs 1,177.60, up 0.4%<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">56.5<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Rs 1,153.21<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Up; support Rs 1,068.48; upper band Rs 1,207.32<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Sun Pharma<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Rs 1,746.90, down 0.25%<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">38.1<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Rs 1,769.12<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Up; support Rs 1,660.69; upper band Rs 1,838.61<\/td>\n<\/tr>\n<\/table>\n<p>Among these F&amp;O stocks to buy, Zydus is the strongest of the three, above its 20-day average with a rising Supertrend. Sun Pharma is below its 20-day average but above its Supertrend support, and CDSL is below its average in a downtrend. The common factor is that none is near an extreme, since all RSI readings are between 37 and 57.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Track F&amp;O stocks and set price alerts on Univest<\/a><\/strong><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Range-Bound_Markets_Matter_for_F_O_Stocks_to_Buy\"><\/span><strong>Why Range-Bound Markets Matter for F&amp;O Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>In the screenshot summary, Jay Thakkar said that markets may stay range-bound ahead of key events and identified support and resistance levels for the Nifty 50 and Bank Nifty. The key events this week are the US Fed decision, the Q2 results season and the Reliance and Jio results on 30 Oct. In a range-bound market, stock-specific picks such as these F&amp;O stocks to buy can work better than index trades, but they can also reverse quickly if the index breaks out. This morning the Sensex was down as much as 995 points on crude above USD 115 and the Nifty touched 22,497, so the range is already being tested.<\/p>\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"text-align:left;padding:8px;border:1px solid #DDDDDD;background:#0A0E1A;color:#FFFFFF;\">F&amp;O stocks to buy: market reading<\/th>\n<th style=\"text-align:left;padding:8px;border:1px solid #DDDDDD;background:#0A0E1A;color:#FFFFFF;\">Level or fact<\/th>\n<th style=\"text-align:left;padding:8px;border:1px solid #DDDDDD;background:#0A0E1A;color:#FFFFFF;\">Note<\/th>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Nifty 50 close, 27 Oct<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">22,749.75<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Slightly lower on the day<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Nifty 50 morning low, 28 Oct<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">22,497<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Down about 1.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Sectors positive in the morning<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Nifty Auto and Nifty Pharma<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Pharma stocks held up better<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Brent crude<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">About USD 115.5 to USD 115.9<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Cost and inflation worry<\/td>\n<\/tr>\n<\/table>\n<p>Pharma was one of only two positive sectors this morning, which fits with Zydus and Sun Pharma being among the F&amp;O stocks to buy. The Nifty IT index fell about 3.5%, so sector choice is doing some of the work.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"CDSL_Share_Price_and_Fundamentals\"><\/span><strong>CDSL Share Price and Fundamentals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"text-align:left;padding:8px;border:1px solid #DDDDDD;background:#0A0E1A;color:#FFFFFF;\">F&amp;O stocks to buy: CDSL metric<\/th>\n<th style=\"text-align:left;padding:8px;border:1px solid #DDDDDD;background:#0A0E1A;color:#FFFFFF;\">Reading<\/th>\n<th style=\"text-align:left;padding:8px;border:1px solid #DDDDDD;background:#0A0E1A;color:#FFFFFF;\">Note<\/th>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Market capitalisation<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">About Rs 25,540 crore<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Provider figure at the previous close<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Price to earnings<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">About 54 times<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Industry about 41.6 times<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Return on equity<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">23.27%<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Strong<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Debt to equity<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">0.00<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">No debt<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Dividend yield<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">About 1%<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Provider figure<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Q1 FY27 revenue and profit<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Rs 340.50 crore and Rs 117.67 crore<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Profit up about 14.9% from Rs 102.40 crore (my calculation)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Q1 FY27 operating margin<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">63.5%<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Very high margin business<\/td>\n<\/tr>\n<\/table>\n<p>CDSL is a depository, so its revenue depends on market activity such as new accounts, transactions and issues. It earns very high margins and carries no debt, but at about 54 times earnings it is priced for growth. Its Supertrend is down, so the near-term trend is weak despite the pick. I did not find the CDSL Q2 results date. Among the F&amp;O stocks to buy, CDSL is the one where the pick and the trend disagree, and the CDSL share price is tied to market activity.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to set price alerts on CDSL and other F&amp;O stocks.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Zydus_Lifesciences_Share_Price_and_Fundamentals\"><\/span><strong>Zydus Lifesciences Share Price and Fundamentals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"text-align:left;padding:8px;border:1px solid #DDDDDD;background:#0A0E1A;color:#FFFFFF;\">F&amp;O stocks to buy: Zydus metric<\/th>\n<th style=\"text-align:left;padding:8px;border:1px solid #DDDDDD;background:#0A0E1A;color:#FFFFFF;\">Reading<\/th>\n<th style=\"text-align:left;padding:8px;border:1px solid #DDDDDD;background:#0A0E1A;color:#FFFFFF;\">Note<\/th>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Market capitalisation<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">About Rs 1,16,409 crore<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Provider figure at the previous close<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Price to earnings<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">About 25.4 times<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Industry about 36.2 times<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Return on equity<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">18.59%<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Healthy<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Debt to equity<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">0.46<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Moderate<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Q1 FY27 revenue<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Rs 8,123.10 crore<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Up about 20.7% from Rs 6,728.60 crore (my calculation)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Q1 FY27 net profit<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Rs 952.40 crore<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Down about 36% from Rs 1,486.60 crore (my calculation)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Q1 FY27 operating margin<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">25.86%<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Down from 34.69% a year earlier<\/td>\n<\/tr>\n<\/table>\n<p>Zydus has growing revenue but a lower margin and profit than a year ago, and that is the key question for the stock. The valuation is below the industry, and the technical trend is up, so the market may be looking through the weaker margin. The Q2 results date was not available in the sources. That mix makes Zydus the most debated of the F&amp;O stocks to buy.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sun_Pharma_Share_Price_and_Fundamentals\"><\/span><strong>Sun Pharma Share Price and Fundamentals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"text-align:left;padding:8px;border:1px solid #DDDDDD;background:#0A0E1A;color:#FFFFFF;\">F&amp;O stocks to buy: Sun Pharma metric<\/th>\n<th style=\"text-align:left;padding:8px;border:1px solid #DDDDDD;background:#0A0E1A;color:#FFFFFF;\">Reading<\/th>\n<th style=\"text-align:left;padding:8px;border:1px solid #DDDDDD;background:#0A0E1A;color:#FFFFFF;\">Note<\/th>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Market capitalisation<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">About Rs 4,22,283 crore<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Provider figure at the previous close<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Price to earnings<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">About 34.9 times<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Industry about 36.2 times<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Return on equity<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">13.74%<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Moderate<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Debt to equity<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">0.06<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Almost debt free<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Q1 FY27 revenue<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Rs 16,023.50 crore<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Up about 11.9% from Rs 14,315.86 crore (my calculation)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Q1 FY27 net profit<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Rs 2,910.80 crore<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Up about 26.4% from Rs 2,302.62 crore (my calculation)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Q1 FY27 operating margin<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">32.52%<\/td>\n<td style=\"padding:8px;border:1px solid #DDDDDD;\">Up from 28.64% a year earlier<\/td>\n<\/tr>\n<\/table>\n<p>Sun Pharma has the most consistent profile of the three, with growing revenue, a higher margin and almost no debt, and its multiple is close to the industry average. The Sun Pharma share price is below the 20-day average of Rs 1,769.12, which shows a short-term pause inside a rising Supertrend. Of the F&amp;O stocks to buy here, Sun Pharma has the most consistent fundamentals, and a move back above the average would help the Sun Pharma share price recover the short-term trend.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risks_When_Trading_F_O_Stocks_to_Buy\"><\/span><strong>Risks When Trading F&amp;O Stocks to Buy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ol>\n<li><strong>Margin-funded risk.<\/strong> Positions in F&amp;O stocks to buy are taken on margin, so a small price move can cause a large loss relative to capital.<\/li>\n<li><strong>Missing levels.<\/strong> The analyst&#8217;s entry, target and stop loss for these F&amp;O stocks to buy were not retrieved, so any trade needs your own levels.<\/li>\n<li><strong>Market weakness.<\/strong> The Sensex fell as much as 995 points this morning, and a break of the range can reverse stock-specific picks.<\/li>\n<li><strong>Event risk.<\/strong> The Fed decision, results and crude oil can gap the market in either direction.<\/li>\n<li><strong>Stock-specific issues.<\/strong> The CDSL share price is in a downtrend, Zydus profit fell in Q1 and CDSL trades at about 54 times earnings.<\/li>\n<\/ol>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion_F_O_Stocks_to_Buy_Need_Defined_Risk\"><\/span><strong>Conclusion: F&amp;O Stocks to Buy Need Defined Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The F&amp;O stocks to buy on Jay Thakkar&#8217;s list, CDSL, Zydus Lifesciences and Sun Pharma, come with a view that markets stay range-bound, and the data shows Zydus and Sun Pharma with a rising Supertrend and CDSL in a downtrend. Without his levels, treat these F&amp;O stocks to buy as a data check and not a trade plan. Set a stop loss, size the position to your own risk profile and verify any levels with the original report.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_F_O_stocks_to_buy_did_Jay_Thakkar_name\"><\/span><strong>Which F&amp;O stocks to buy did Jay Thakkar name?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The headline names CDSL, Zydus Lifesciences and Sun Pharma as near-term F&amp;O stocks to buy by ICICI Securities&#8217; Jay Thakkar. I could not retrieve his entry zones, targets or stop losses.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Jay_Thakkars_view_on_the_market\"><\/span><strong>What is Jay Thakkar&#8217;s view on the market?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> He said markets may stay range-bound ahead of key events after the Sensex and Nifty ended slightly lower on Tuesday amid elevated oil prices and geopolitical uncertainty, and he identified support and resistance levels for the Nifty 50 and Bank Nifty, which I could not retrieve. His list of F&amp;O stocks to buy sits inside this view.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_CDSL_share_price_and_technicals\"><\/span><strong>What are the CDSL share price and technicals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> CDSL was Rs 1,223.60 on the NSE at 11:26 AM, with an RSI of 37.7, a 20-day EMA of Rs 1,249.03 and a Supertrend downtrend with resistance at Rs 1,280.73. The trailing price to earnings is about 54 times.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_Zydus_Lifesciences_share_price_and_technicals\"><\/span><strong>What are the Zydus Lifesciences share price and technicals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Zydus was Rs 1,177.60, with an RSI of 56.5, a 20-day EMA of Rs 1,153.21 and a rising Supertrend with support at Rs 1,068.48. Q1 FY27 profit fell about 36% while revenue rose about 20.7%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_Sun_Pharma_share_price_and_technicals\"><\/span><strong>What are the Sun Pharma share price and technicals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sun Pharma was Rs 1,746.90, with an RSI of 38.1, a 20-day EMA of Rs 1,769.12 and a rising Supertrend with support at Rs 1,660.69. Q1 FY27 profit rose about 26.4% and the price to earnings is about 34.9 times. Of these F&amp;O stocks to buy, it has the steadiest growth.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_find_the_original_report_with_the_levels\"><\/span><strong>Where can I find the original report with the levels?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The original ICICI Securities note by Jay Thakkar would carry the entry zones, targets and stop losses. I could not retrieve it, so please check the broker&#8217;s research page or the news report before using any level for these F&amp;O stocks to buy.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Are_F_O_stocks_to_buy_safe_for_beginners\"><\/span><strong>Are F&amp;O stocks to buy safe for beginners?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. Futures and options are margin-based, so losses can exceed expectations. Beginners should understand the contracts, position size and stop losses first, and nothing here is advice.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_article_investment_advice\"><\/span><strong>Is this article investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. It is educational and not a recommendation to buy or sell. Please check the figures against company filings and your own risk profile before you act on anything you read here.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which F&amp;O stocks to buy did Jay Thakkar name?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The headline names CDSL, Zydus Lifesciences and Sun Pharma as near-term F&amp;O stocks to buy by ICICI Securities' Jay Thakkar. I could not retrieve his entry zones, targets or stop losses.\"}},{\"@type\":\"Question\",\"name\":\"What is Jay Thakkar's view on the market?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"He said markets may stay range-bound ahead of key events after the Sensex and Nifty ended slightly lower on Tuesday amid elevated oil prices and geopolitical uncertainty, and he identified support and resistance levels for the Nifty 50 and Bank Nifty, which I could not retrieve. His list of F&amp;O stocks to buy sits inside this view.\"}},{\"@type\":\"Question\",\"name\":\"What are the CDSL share price and technicals?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"CDSL was Rs 1,223.60 on the NSE at 11:26 AM, with an RSI of 37.7, a 20-day EMA of Rs 1,249.03 and a Supertrend downtrend with resistance at Rs 1,280.73. The trailing price to earnings is about 54 times.\"}},{\"@type\":\"Question\",\"name\":\"What are the Zydus Lifesciences share price and technicals?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Zydus was Rs 1,177.60, with an RSI of 56.5, a 20-day EMA of Rs 1,153.21 and a rising Supertrend with support at Rs 1,068.48. Q1 FY27 profit fell about 36% while revenue rose about 20.7%.\"}},{\"@type\":\"Question\",\"name\":\"What are the Sun Pharma share price and technicals?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Sun Pharma was Rs 1,746.90, with an RSI of 38.1, a 20-day EMA of Rs 1,769.12 and a rising Supertrend with support at Rs 1,660.69. Q1 FY27 profit rose about 26.4% and the price to earnings is about 34.9 times. Of these F&amp;O stocks to buy, it has the steadiest growth.\"}},{\"@type\":\"Question\",\"name\":\"Where can I find the original report with the levels?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The original ICICI Securities note by Jay Thakkar would carry the entry zones, targets and stop losses. I could not retrieve it, so please check the broker's research page or the news report before using any level for these F&amp;O stocks to buy.\"}},{\"@type\":\"Question\",\"name\":\"Are F&amp;O stocks to buy safe for beginners?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. Futures and options are margin-based, so losses can exceed expectations. Beginners should understand the contracts, position size and stop losses first, and nothing here is advice.\"}},{\"@type\":\"Question\",\"name\":\"Is this article investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. It is educational and not a recommendation to buy or sell. Please check the figures against company filings and your own risk profile before you act on anything you read here.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>F&#038;O stocks to buy named by Jay Thakkar: CDSL, Zydus Lifesciences and Sun Pharma. See price levels, technicals, fundamentals and risks, and why range-bound markets matter.<\/p>\n","protected":false},"author":29,"featured_media":330132,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3022,17042,17048,17045,17043,17046,17047,1007,318,17044],"class_list":["post-330133","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-cdsl-share-price","tag-fo-stocks-to-buy","tag-fo-stocks-today","tag-icici-securities-stock-picks","tag-jay-thakkar","tag-near-term-stock-picks","tag-nifty-range-bound","tag-pharma-stocks","tag-sun-pharma-share-price","tag-zydus-lifesciences-share-price"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["330132"],"rank_math_title":["F&amp;O Stocks to Buy: CDSL, Zydus Life, Sun Pharma Levels"],"rank_math_description":["F&amp;O stocks to buy named by Jay Thakkar: CDSL, Zydus Lifesciences and Sun Pharma. See price levels, technicals, fundamentals and risks, and why range-bound markets matter."],"rank_math_focus_keyword":["F&O stocks to buy"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/f-and-amp-o-stocks-to-buy-cdsl-zydus-lifesciences-and-sun-pharma-on-jay-thakkar.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/330133","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=330133"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/330133\/revisions"}],"predecessor-version":[{"id":330134,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/330133\/revisions\/330134"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/330132"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=330133"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=330133"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=330133"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}